CAMBRIDGE, Mass., Sept. 7, 2011 /PRNewswire/ -- Sermo, Inc. (www.sermo.com), the largest online physician network in the United States, today announced the launch of Sermo Sponsorship, a portfolio of offerings that provides new opportunities for pharmaceutical, biotechnology and life sciences companies to engage physicians and educate them on new products and programs. Sermo Sponsorship is available on both web and mobile platforms, where physicians across 68 specialties discuss top issues in healthcare and consult each other on clinical cases in order to provide the highest quality care to their patients.
Companies can use Sermo Sponsorship to drive awareness of drugs or devices or communicate new clinical and indication data. The Sermo network facilitates discussion and peer influence, creating a multiplier effect that reinforces key takeaways and increases the number of physicians exposed to the new information.
"Whether companies are launching new treatments or sharing new data from clinical trials, Sermo Sponsorship enables them to reach, engage and influence the treatment decisions of their target specialists," said Jon Michaeli, Vice President of Marketing at Sermo. "Industry research shows that peer influence has the greatest impact on clinical decisions. Sermo's social platform makes it easy for physicians to share new industry developments with their colleagues."
According to the Manhattan Research study, Taking the Pulse® v11.0, released in May 2011, information physicians receive from colleague consults has the greatest influence on their clinical decisions, and healthcare provider portal sites have the broadest reach amongst online physicians. The study also shows that of the 24% of physicians already using online communities or social networks, 84% have visited Sermo in t
Copyright©2010 PR Newswire.
All rights reserved